BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 6394263)

  • 1. Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis.
    Clissold SP; Heel RC
    Drugs; 1984 Dec; 28(6):485-518. PubMed ID: 6394263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triamcinolone acetonide. A review of its pharmacological properties and therapeutic efficacy in the management of allergic rhinitis.
    Jeal W; Faulds D
    Drugs; 1997 Feb; 53(2):257-80. PubMed ID: 9028745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budesonide. An updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis.
    Brogden RN; McTavish D
    Drugs; 1992 Sep; 44(3):375-407. PubMed ID: 1382936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beclomethasone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 Aug; 28(2):99-126. PubMed ID: 6381025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the efficacy and patient acceptability of budesonide and beclomethasone dipropionate aqueous nasal sprays in patients with perennial rhinitis.
    Adamopoulos G; Manolopoulos L; Giotakis I
    Clin Otolaryngol Allied Sci; 1995 Aug; 20(4):340-4. PubMed ID: 8548967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A risk-benefit assessment of intranasal triamcinolone acetonide in allergic rhinitis.
    Gawchik SM; Saccar CL
    Drug Saf; 2000 Oct; 23(4):309-22. PubMed ID: 11051218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of budesonide and beclomethasone dipropionate sprays in the treatment of seasonal allergic rhinitis.
    McArthur JG
    Clin Otolaryngol Allied Sci; 1994 Dec; 19(6):537-42. PubMed ID: 7895388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flunisolide: a review of its pharmacological properties and therapeutic efficacy in rhinitis.
    Pakes GE; Brogden RN; Heel RD; Speight TM; Avery GS
    Drugs; 1980 Jun; 19(6):397-411. PubMed ID: 6771116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of eight months of inhaled beclomethasone dipropionate and budesonide on carbohydrate metabolism in adults with asthma.
    Kiviranta K; Turpeinen M
    Thorax; 1993 Oct; 48(10):974-8. PubMed ID: 8256243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical comparison of intranasal budesonide with beclomethasone dipropionate for perennial non-allergic rhinitis: a 12 month study.
    Synnerstad B; Lindqvist N
    Br J Clin Pract; 1996; 50(7):363-6. PubMed ID: 9015907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal corticosteroids for allergic rhinitis.
    Trangsrud AJ; Whitaker AL; Small RE
    Pharmacotherapy; 2002 Nov; 22(11):1458-67. PubMed ID: 12432972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis.
    McNeely W; Wiseman LR
    Drugs; 1998 Jul; 56(1):91-114. PubMed ID: 9664202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Budesonide].
    Mokr K
    Dtsch Med Wochenschr; 1995 Jan; 120(4):111-2. PubMed ID: 7835236
    [No Abstract]   [Full Text] [Related]  

  • 14. Mometasone furoate. A review of its intranasal use in allergic rhinitis.
    Onrust SV; Lamb HM
    Drugs; 1998 Oct; 56(4):725-45. PubMed ID: 9806113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety update regarding intranasal corticosteroids for the treatment of allergic rhinitis.
    Blaiss MS
    Allergy Asthma Proc; 2011; 32(6):413-8. PubMed ID: 22221434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal inhalation of the glucocorticoid budesonide from a spacer for the treatment of patients with pollen rhinitis and asthma.
    Pedersen B; Dahl R; Lindqvist N; Mygind N
    Allergy; 1990 Aug; 45(6):451-6. PubMed ID: 2244675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double blind comparison of intranasal budesonide 400 micrograms and 800 micrograms in perennial rhinitis.
    Wight RG; Jones AS; Beckingham E; Andersson B; Ek L
    Clin Otolaryngol Allied Sci; 1992 Aug; 17(4):354-8. PubMed ID: 1526057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of allergic rhinitis: focus on intranasal agents.
    Dushay ME; Johnson CE
    Pharmacotherapy; 1989; 9(6):338-50. PubMed ID: 2575739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of safety of concurrent use of intranasal flunisolide and oral beclomethasone aerosols in treatment of asthmatics with rhinitis.
    Toogood JH; Jennings B; Crepea SB; Johnson JD
    Clin Allergy; 1982 Jan; 12(1):95-105. PubMed ID: 7067071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A parallel-group comparison of budesonide and beclomethasone dipropionate for the treatment of perennial allergic rhinitis in adults.
    al-Mohaimeid H
    J Int Med Res; 1993; 21(2):67-73. PubMed ID: 8243791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.